An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses-Reference-Cited by-同舟云学术

An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses

Published:2007-10 Issue:42 Volume:25 Page:7339-7353
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Fournillier A.,Gerossier E.,Evlashev A.,Schmitt D.,Simon B.,Chatel L.,Martin P.,Silvestre N.,Balloul J.M.,Barry R.,Inchauspé G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference61 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Natural history of chronic hepatitis C;Seeff;Hepatology,2002

3. Past, present, and future hepatitis C treatments;Foster;Semin Liver Dis,2004

4. New therapies for chronic hepatitis C virus infection;Dev;Curr Gastroenterol Rep,2004

5. Cell-mediated immunity and the outcome of hepatitis C virus infection;Shoukry;Annu Rev Microbiol,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches;Journal of Medical Virology;2024-09

2. Therapeutic strategies and promising vaccine for hepatitis C virus infection;Immunity, Inflammation and Disease;2023-08

3. Hepatitis C Vaccines;Plotkin's Vaccines;2023

4. Development of therapeutic vaccines for the treatment of diseases;Molecular Biomedicine;2022-12-08

5. A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB/c mice model;Molecular Immunology;2019-07